5-iPF2α-VI-d11 (50 ug) (±)5,9.alpha.,11.alpha.-trihydroxy-(8.beta.)-prosta-6E,14Z-dien-1-oic-16,16,17,17,18,18,19,19,20,20,20-d11 acid; 5-iPF2α-VI-d11 Cayman 10006654-50 规格或产品已更新 详情
5-iPF2α-VI-d11 (100 ug) (±)5,9.alpha.,11.alpha.-trihydroxy-(8.beta.)-prosta-6E,14Z-dien-1-oic-16,16,17,17,18,18,19,19,20,20,20-d11 acid; 5-iPF2α-VI-d11 Cayman 10006654-100 规格或产品已更新 详情
Ketoprofen (1 g) 3-benzoyl-.alpha.-methyl-benzeneacetic acid; Orudis|Oruvail|2-(3-benzoylphenyl)propionic Acid; Ketoprofen Cayman 10006661-1 123.2/1 g 详情
Ketoprofen (10 g) 3-benzoyl-.alpha.-methyl-benzeneacetic acid; Orudis|Oruvail|2-(3-benzoylphenyl)propionic Acid; Ketoprofen Cayman 10006661-10 985.6/10 g 详情
Ketoprofen (25 g) 3-benzoyl-.alpha.-methyl-benzeneacetic acid; Orudis|Oruvail|2-(3-benzoylphenyl)propionic Acid; Ketoprofen Cayman 10006661-25 2156/25 g 详情
Ketoprofen (5 g) 3-benzoyl-.alpha.-methyl-benzeneacetic acid; Orudis|Oruvail|2-(3-benzoylphenyl)propionic Acid; Ketoprofen Cayman 10006661-5 554.4/5 g 详情
(+)-15-epi Cloprostenol (1 mg) (+)-9α,11α,15S-trihydroxy-16-(3-chlorophenoxy)-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-oic acid; (+)-15(S)-Cloprostenol|D-Cloprostenol; (+)-15-epi Cloprostenol Cayman 10006692-1 600.6/1 mg 详情
(+)-15-epi Cloprostenol (10 mg) (+)-9α,11α,15S-trihydroxy-16-(3-chlorophenoxy)-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-oic acid; (+)-15(S)-Cloprostenol|D-Cloprostenol; (+)-15-epi Cloprostenol Cayman 10006692-10 4804.8/10 mg 详情
(+)-15-epi Cloprostenol (5 mg) (+)-9α,11α,15S-trihydroxy-16-(3-chlorophenoxy)-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-oic acid; (+)-15(S)-Cloprostenol|D-Cloprostenol; (+)-15-epi Cloprostenol Cayman 10006692-5 2710.4/5 mg 详情
(+)-15-epi Cloprostenol (50 mg) (+)-9α,11α,15S-trihydroxy-16-(3-chlorophenoxy)-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-oic acid; (+)-15(S)-Cloprostenol|D-Cloprostenol; (+)-15-epi Cloprostenol Cayman 10006692-50 21021/50 mg 详情
HEPC (10 mg) 4-oxide-4-hydroxy-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-thia-4-phosphatetracosan-1-aminium, inner salt; 2-Hexadecanoylthio-1-Ethylphosphorylcholine; HEPC Cayman 10006695-10 3742.2/10 mg 详情
HEPC (25 mg) 4-oxide-4-hydroxy-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-thia-4-phosphatetracosan-1-aminium, inner salt; 2-Hexadecanoylthio-1-Ethylphosphorylcholine; HEPC Cayman 10006695-25 8870.4/25 mg 详情
HEPC (5 mg) 4-oxide-4-hydroxy-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-thia-4-phosphatetracosan-1-aminium, inner salt; 2-Hexadecanoylthio-1-Ethylphosphorylcholine; HEPC Cayman 10006695-5 1971.2/5 mg 详情
HEPC (50 mg) 4-oxide-4-hydroxy-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-thia-4-phosphatetracosan-1-aminium, inner salt; 2-Hexadecanoylthio-1-Ethylphosphorylcholine; HEPC Cayman 10006695-50 15769.6/50 mg 详情
Prostaglandin D2-biotin (50 ug) 9.alpha.,15S-dihydroxy-11-oxo-prosta-5Z,13E-dien-1-oyl-N’-biotinoyl-1,5-diaminopentane; PGD2-biotin; Prostaglandin D2-biotin Cayman 10006697-50 893.2/50 ug 详情
Prostaglandin D2-biotin (100 ug) 9.alpha.,15S-dihydroxy-11-oxo-prosta-5Z,13E-dien-1-oyl-N’-biotinoyl-1,5-diaminopentane; PGD2-biotin; Prostaglandin D2-biotin Cayman 10006697-100 1694/100 ug 详情
Prostaglandin D2-biotin (500 ug) 9.alpha.,15S-dihydroxy-11-oxo-prosta-5Z,13E-dien-1-oyl-N’-biotinoyl-1,5-diaminopentane; PGD2-biotin; Prostaglandin D2-biotin Cayman 10006697-500 5898.2/500 ug 详情
Prostaglandin D2-biotin (1 mg) 9.alpha.,15S-dihydroxy-11-oxo-prosta-5Z,13E-dien-1-oyl-N’-biotinoyl-1,5-diaminopentane; PGD2-biotin; Prostaglandin D2-biotin Cayman 10006697-1 10364.2/1 mg 详情
PD 98059 (1 mg) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; PD 98059 Cayman 10006726-1 184.8/1 mg 详情
PD 98059 (10 mg) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; PD 98059 Cayman 10006726-10 1001/10 mg 详情
PD 98059 (5 mg) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; PD 98059 Cayman 10006726-5 693/5 mg 详情
PD 98059 (50 mg) 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; PD 98059 Cayman 10006726-50 4004/50 mg 详情
PD 169316 (1 mg) 4-[5-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-4-yl]-pyridine; PD 169316 Cayman 10006727-1 754.6/1 mg 详情
PD 169316 (10 mg) 4-[5-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-4-yl]-pyridine; PD 169316 Cayman 10006727-10 2109.8/10 mg 详情
PD 169316 (25 mg) 4-[5-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-4-yl]-pyridine; PD 169316 Cayman 10006727-25 4527.6/25 mg 详情
PD 169316 (5 mg) 4-[5-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-4-yl]-pyridine; PD 169316 Cayman 10006727-5 1201.2/5 mg 详情
VDM11 (10 mg) N-(4-hydroxy-2-methylphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide; VDM11 Cayman 10006731-10 970.2/10 mg 详情
VDM11 (25 mg) N-(4-hydroxy-2-methylphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide; VDM11 Cayman 10006731-25 2294.6/25 mg 详情
VDM11 (5 mg) N-(4-hydroxy-2-methylphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide; VDM11 Cayman 10006731-5 508.2/5 mg 详情
VDM11 (50 mg) N-(4-hydroxy-2-methylphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide; VDM11 Cayman 10006731-50 4065.6/50 mg 详情
QNZ (1 mg) N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine; CAY1047QNZ Cayman 10006734-1 446.6/1 mg 详情
QNZ (10 mg) N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine; CAY1047QNZ Cayman 10006734-10 3234/10 mg 详情
QNZ (5 mg) N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine; CAY1047QNZ Cayman 10006734-5 1848/5 mg 详情
QNZ (500 ug) N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine; CAY1047QNZ Cayman 10006734-500 231/500 ug 详情
CAY10471 (1 mg) (+)-3-[[(4-fluorophenyl)sulfonyl]methylamino]-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid; CAY10471 Cayman 10006735-1 831.6/1 mg 详情
CAY10471 (10 mg) (+)-3-[[(4-fluorophenyl)sulfonyl]methylamino]-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid; CAY10471 Cayman 10006735-10 6652.8/10 mg 详情
CAY10471 (5 mg) (+)-3-[[(4-fluorophenyl)sulfonyl]methylamino]-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid; CAY10471 Cayman 10006735-5 3742.2/5 mg 详情
CAY10471 (50 mg) (+)-3-[[(4-fluorophenyl)sulfonyl]methylamino]-1,2,3,4-tetrahydro-9H-carbazole-9-acetic acid; CAY10471 Cayman 10006735-50 29106/50 mg 详情
14,15-Leukotriene C4 AChE Tracer (100 dtn) 14,15-Leukotriene C4 AChE Tracer Cayman 10006750-100 规格或产品已更新 详情
14,15-Leukotriene C4 AChE Tracer (500 dtn) 14,15-Leukotriene C4 AChE Tracer Cayman 10006750-500 规格或产品已更新 详情
14,15-Leukotriene C4 EIA Antiserum (100 dtn) 14,15-Leukotriene C4 EIA Antiserum Cayman 10006751-100 规格或产品已更新 详情
14,15-Leukotriene C4 EIA Antiserum (500 dtn) 14,15-Leukotriene C4 EIA Antiserum Cayman 10006751-500 规格或产品已更新 详情
14,15-Leukotriene C4 EIA Standard (1 ea) 14,15-Leukotriene C4 EIA Standard Cayman 10006752-1 规格或产品已更新 详情
Oleic Acid-2,6-diisopropylanilide (10 mg) N-[2,6-bis(1-methylethyl)phenyl]-9Z-octadecenamide; Oleic Acid-2,6-diisopropylanilide Cayman 10006782-10 785.4/10 mg 详情
Oleic Acid-2,6-diisopropylanilide (5 mg) N-[2,6-bis(1-methylethyl)phenyl]-9Z-octadecenamide; Oleic Acid-2,6-diisopropylanilide Cayman 10006782-5 415.8/5 mg 详情
Oleic Acid-2,6-diisopropylanilide (50 mg) N-[2,6-bis(1-methylethyl)phenyl]-9Z-octadecenamide; Oleic Acid-2,6-diisopropylanilide Cayman 10006782-50 3326.4/50 mg 详情
(+)-Xestospongin A (100 ug) [1R-(1R*,4aR*,11R*,12aS*,13R*,16aR*,23R*,24aS*)]-eicosahydro-5H,17H-1,23:11,13-diethano-2H,14H-[1,11]dioxacyclo-eicosino[2,3-b:12,13-b’]dipyridine; Araguspongin D|XeA; (+)-Xestospongin A Cayman 10006794-100 规格或产品已更新 详情
(+)-Xestospongin A (250 ug) [1R-(1R*,4aR*,11R*,12aS*,13R*,16aR*,23R*,24aS*)]-eicosahydro-5H,17H-1,23:11,13-diethano-2H,14H-[1,11]dioxacyclo-eicosino[2,3-b:12,13-b’]dipyridine; Araguspongin D|XeA; (+)-Xestospongin A Cayman 10006794-250 规格或产品已更新 详情
Araguspongin B (100 ug) [1R-(1R*,4aR*,11S*,12aR*,13R*,16aR*,23S*,24aR*)]-eicosahydro-5H,17H-1,23:11,13-diethano-2H,14H-[1,11]dioxacycloeicosino[2,3-b:12,13-b’]dipyridine; Araguspongin B Cayman 10006797-100 5035.8/100 ug 详情
Araguspongin B (250 ug) [1R-(1R*,4aR*,11S*,12aR*,13R*,16aR*,23S*,24aR*)]-eicosahydro-5H,17H-1,23:11,13-diethano-2H,14H-[1,11]dioxacycloeicosino[2,3-b:12,13-b’]dipyridine; Araguspongin B Cayman 10006797-250 11965.8/250 ug 详情
首页 公司简介 新闻中心 产品中心 特色产品 技术专栏 在线订购 联系我们

版权所有 艾美捷科技有限公司

地址:武汉市洪山区光谷大道35号光谷总部国际二期时代1栋13楼 邮政编码:430074

电话:+86-027-59626688 全国免费技术支持: 400-6800-868 传真:+86-027-59716800

鄂ICP备10204150号

Abbkine Scientific   亚科因科技